Crippa Prado Carla Smith de Vasconcellos sold $188K of ABEV

Crippa Prado Carla Smith de Vasconcellos (See Remarks) sold 60,757 shares of AMBEV S.A. (ABEV) at $3.09 ($0.19M total) on 2026-09-03.

Original reporting
SEC EDGAR · Crippa Prado Carla Smith de Vasconcellos
Published Oct 8, 2026, 9:23 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 8, 2026, 9:26 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ABEV
Bearish
high confidence
Mentioned
$ABEV
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ABEVBearishLow
01

Why it matters

The modest sale may generate slight short‑term pressure but is unlikely to move the stock materially.

02

Market read

A routine insider sale with limited trading relevance.

03

What to watch

The insider still holds a sizable stake, and no other material news accompanies the filing.

Relevance 4/10Novelty 3/10Timing: filing day

Background

SEC Form 4 filing discloses an insider's open‑market sale of Ambev shares.

Company-level read

Ticker impact

$ABEVBearishHigh confidence
Context

Officer Crippa Prado Carla Smith de Vasconcellos sold 60,757 shares of Ambev at $3.09 each, total $187,739, reducing her holdings to 80,707 shares.

Expected impact

likely modest pressure as the market prices in the insider sell

Evidence & confidence

The transaction amount is under $200k and the insider remains a significant holder, so the impact is limited but could be viewed as a weak negative signal.

Market effects

Minimal effect on the beverage sector; the sale is too small to shift sector sentiment.

Limited impact on Brazilian market perception of Ambev.

Low; the filing is a routine insider transaction with no broader market relevance.

Counterpoint

The sale could be a routine portfolio rebalancing and not indicative of any fundamental concerns.

Key entities

  • Ambev S.A.

    Brazilian brewing company listed in the US as ABEV.

  • Crippa Prado Carla Smith de Vasconcellos

    Company officer who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ABEVMedAI 8/10

Ambev Q3 2026 slides: margin expansion amid modest volume gains

Ambev (NYSE: ABEV) reported Q3 2026 results with net revenue growth of 7.6%, EBITDA growth of 8.9%, and EPS growth of 15.4%, despite a 0.8% volume increase. The company beat EPS estimates but missed on revenue, with shares initially falling 4.32% before recovering 1.88%. Ambev's strategy focuses on profitability and margin expansion, with regional diversification and digital platform growth.

$ABEVMedAI 8/10

Ambev (ABEV) Q3 2026 Earnings Call Transcript

Ambev (ABEV) reported Q3 2026 earnings with total volumes up 0.7%, beer volumes growing faster. Net revenue increased 7.3%, EBITDA up 9.3%, and EPS up 12.3%. The company invested heavily in growth, with market investments up double digits. Brazil's beer market showed sequential recovery, with volume growth of 2.7% over Q2 and Q3. Ambev gained market share in premium and zero-alcohol segments.

$ABEVMed

Brazil Brewer Ambev Profit Falls 10%

Ambev (ABEV) reported a 10.2% drop in third-quarter profit to R$4.37 billion (US$816 million), partly due to a one-off gain from operations a year earlier. Normalized profit rose 14.3% to R$4.39 billion (US$821 million). Revenue increased 3.6% to R$21.6 billion (US$4.04 billion), driven by higher prices. The company approved a share buyback program of up to 190 million shares.

$ABEVHighAI 8/10

AMBEV S.A. (ABEV): Financial results for Q3 2026

AMBEV S.A. (ABEV) furnished an SEC Form 6-K — earnings release. Yes _______ No ___X____ Page | 1 AMBEV REPORTS 2026 THIRD QUARTER RESULTS [1] “The third quarter built on the progress we achieved in the first half of the year, with the consistent execution of our strategy delivering growth in volumes, net revenue and Normalized EBITDA, alongsi